To The Moon

$BE 20261002 310.0 CALL$ Closed and profit take

$BE 20260925 290.0 CALL$ Closed and profit take

$Defiance Daily Target 2X Long SMCI ETF(SMCX)$ $SUPER MICRO COMPUTER INC(SMCI)$  Feels Bullish. Aim for 200% again near-term.  Super Micro Says AI Opportunity Could Reach $4 Trillion: ‘The Sky’s the Limit’

$LCID 20261002 4.0 PUT$ 1️⃣ Why am I making this trade now? Selling a LCID $4 Put here is a calculated bullish income trade, not a momentum bet. LCID has pulled back after recent volatility, but the $4 level looks like a price I’m comfortable owning shares if assigned. Rather than chasing the stock, I’m getting paid a premium while waiting. My thesis is simple: * Near-term downside appears more limited around this strike than the recent highs/lows suggest. * Elevated implied volatility means option premiums are still attractive. * If LCID stays above $4, I keep the premium. If it falls below $4, I’m prepared to own the shares at an effective cost basis below the strike after premium received. 2️⃣ What’s my plan from he

1. What's Happening Today Rates Side Leans Pressured, But Tech Sees Selective Catalysts. TLT Falls for a Second Consecutive Day: Treasury yields continue rising, with the market repricing roughly 40bp of cumulative hikes this year. The probability of an October FOMC hike has risen to about 70%. QQQ Rebounds, Crude Oil Pulls Back: The U.S. and Iran are discussing a phased reopening of the Strait of Hormuz, easing energy supply risks. AI Infrastructure Diverges: ORCL delayed payment arrangements for its Jupiter data center project, and ARM weakened on Jupiter order exposure. Anthropic signed a 7-year CPU capacity commitment with AKAM, lifting AKAM, INTC, and AMD. IWM: Currently stuck at the 30-week MA. Watch today whether it retests the 60-week MA or reclaims the 30-week MA. 2. What Money Is

🐯 Hey Tigers! The market is giving us three very different setups this morning. 1. $Oracle(ORCL)$ Trading below short-term support. For me, $140 is the level that matters this week. A recovery and weekly close back above it would help stabilize the chart. If $140 turns into confirmed resistance instead, I’d be watching the low $120s as the next major downside area. So far, the chart is still in defense mode. 2. $Cipher Mining Inc.(CIFR)$ Yesterday’s short-term target was hit. 🎯 That move played out, but I’m not expecting a straight line toward the longer-term $30 target. A pullback toward $16 would not surprise me before the next potential leg higher. That would simply be a deeper reset inside the larger

📊 Market Recap U.S. Eastern Time on September 25, Qualcomm closed at $194.26, down -1.51% with a daily amplitude of 2.55%. The stock now sits roughly 25% below its 52-week high of $259.92, pressured by cooling momentum after a strong September run. 🚀 Key Drivers Data Center Supply Chain Stress: Oracle's force majeure notice on a New Mexico data center raised concerns about AI infrastructure delays, weighing on semiconductor sentiment broadly. Profit-Taking After Rally: QCOM gained sharply in early September before fading; short volume ratios remained elevated near 24% on September 22, indicating active bearish positioning. Valuation Reset: With forward P/E at 18.74 versus a historical average of 15.14, investors are recalibrating expectations for Qualcomm's AI and auto pipeline execution.

📊 Market Recap As of September 25, 2026, 'CRWV' closed at $90.13, up +3.72% on the day with an intraday range of $85.94 to $91.12, posting an amplitude of 5.97%. The stock remains 41.2% below its 52-week high of $153.20, while sitting roughly 48.9% above its 52-week low of $60.55. Volume reached 33.61 million shares with a volume ratio of 0.69, suggesting the rally is not yet fully confirmed by participation, but price action is firming above the prior $86.90 close. 🚀 Key Drivers AI Cloud Momentum: On September 22, US AI cloud service providers rallied collectively, with 'CRWV' gaining nearly 3% alongside peers such as 'NBIS', 'ORCL', and 'GOOGL', reflecting renewed investor appetite for AI infrastructure names. Data Center Sentiment Shift: Oracle's force majeure notice at its New Mexico d

📊 Market Recap As of September 25, 2026 (ET), 'INTC' closed at $127.39, up +$4.79 or +3.91%, with an intraday amplitude of 6.44%. The stock is now only about 10.5% below its 52-week high of $142.35 and has decisively broken above the previous resistance zone near $122.60. 🚀 Key Drivers Foundry Momentum: Intel's aggressive push in advanced node manufacturing and AI-adjacent semiconductor capacity is keeping institutional interest elevated, with the stock moving from a 52-week low of $29.23 to triple-digit territory in under a year. Capital Inflows: One-day capital flow data shows total inflows of RMB 5.56 billion versus outflows of RMB 5.44 billion, with large order buying at RMB 1.00 billion, indicating sustained accumulation by bigger players. Macro Rotation: Broader semiconductor sentime

1. What's Happening Today Middle East Risk Escalates: U.S.-Iran talks remain deadlocked, the Strait of Hormuz shows no prospect of reopening, and Brent has broken above $100 again. Long-End Rates Rising: U.S. 10Y and 30Y Treasury yields have climbed to multi-year highs, with the market re-trading the "higher rates for longer / further hikes" narrative. AI Entry-Point Competition Heats Up: Meta positions Muse as its core consumer AI product, targeting 1 billion users; OpenAI is rumored to launch a personal Agent as soon as this week; Google, threatened by AI Agents, fell 3.8% yesterday. 2. What Money Is Betting On / Defending Against Defending Against Two Things: Oil Prices + Tech Pullback. 🟠 Buy Side VIX | 2026/12/16 14 Call — 25,600 contracts.

$HOOD 20261002 145.0 CALL$ Limit order filled to sell Hood call at high $145 strike for credit during trump-xi sumit event driven price increase 

$PLTR 20261002 200.0 CALL$ Just a small income for me to spend. Hahaha. Don't follow arh

$TSM VERTICAL 261030 PUT 415.0/PUT 420.0$ TSM is on very tight range, even today were most of the megacaps dip much lower. Taking this opportunity to add position.

$Amazon.com(AMZN)$ Sold off some of the existing holding to get some profits off the table in view of the market volatility. This would also help to preserve my margin. The key objective is not to blow up the account and let the account lives to fight another day. The profits is determined when you entered the trade. And to exit to manage the risk. Will continue to monitor if I should sell off more... 

🌟🌟🌟 $SanDisk Corp.(SNDK)$ is currently like a lightning rod.  The structural need for memory is real, making a strong case for a supercycle.  However the price you are paying for that future is heavily intoxicated by peak market sentiment. History screams a warning to those buying at the top.  At these levels even a tiny piece of bad news, a minor shipping delay or a change in a single customer's budget could trigger a brutal avalanche. It is much better to buy $VanEck Semiconductor ETF(SMH)$ compared to buying just SanDisk alone.  That way if SanDisk has a bad day, your portfolio is protected by othe

For me, the biggest expectation is seeing how Greg Abel manages $Berkshire Hathaway(BRK.A)$ $Berkshire Hathaway(BRK.B)$ Berkshire’s huge capital base without losing the discipline that built the company. With around $365 billion in cash and Treasuries, capital allocation will be one of the key things I watch. My biggest concern is whether Berkshire can maintain the same level of shareholder trust without Warren Buffett making the major decisions. Abel’s recent moves give us some early clues, but the real test will be how consistently he allocates capital through different market cycles. Personally, I still see Berkshire as a long-term compounder rather than simply a “Buffett stock.” I will be watchin

$IX Biopharma(42C.SI)$ 0.8 Target Price. --Ix Biopharama Medical Breakthrough-- iX Biopharma achieved a major medical and commercial breakthrough with Wafermine, its patented sublingual (under-the-tongue) ketamine wafer for non-opioid acute pain management. --The Core Technology-- WaferiXFast Absorption: Wafers dissolve sublingually in minutes, letting active ingredients enter the bloodstream directly and bypass the gut. High Bioavailability: Provides a needle-free, predictable alternative to intravenous infusions or standard oral pills. Drug Repurposing: Applies the delivery system to central nervous system agents and other urgent indications. --Key Pipeline & Commercial Milestones-- Backed by a US$40.95 million contract from the US Departm

For me, the biggest thing to watch is whether $Meta Platforms, Inc.(META)$ Muse can turn the initial download momentum into regular usage. Reaching No. 1 on the App Store is encouraging, but retention and daily usage will matter much more than launch-day excitement. I am also watching monetization closely. Meta already has massive distribution, so if Muse can eventually connect subscriptions, commerce and transactions, it could create a new revenue stream beyond advertising. But Amazon’s decision to block Muse also shows that platform access could become a major hurdle. Personally, I think the next phase is about proving the full cycle: adoption → retention → transactions → monetization. I would not judge Muse purely by the stock reaction yet.